Dapsone topical

Drug Profile

Dapsone topical

Alternative Names: 5% Topical dapsone gel - Novelion Therapeutics; 7.5% Topical dapsone gel - Allergan; Aczone; Atrisone

Latest Information Update: 30 Nov 2016

Price : $50

At a glance

  • Originator QLT
  • Developer Allergan; Novelion Therapeutics
  • Class Anti-inflammatories; Antiacnes; Antibacterials; Antileprotics; Antimalarials; Small molecules; Sulfones
  • Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Acne

Most Recent Events

  • 29 Nov 2016 QLT acquired Aegerion Pharmaceuticals and later QLT changed its name to Novelion Therapeutics
  • 06 Jun 2016 Launched for Acne in USA (Topical)
  • 15 Mar 2016 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top